NM_000180.4(GUCY2D):c.937C>T (p.Arg313Cys) is a missense variant predicted to replace arginine with cysteine at position p.313. This variant is present in gnomAD v4.1.0 at a total allele frequency of 0.000009334, with 15 alleles / 1,607,084 total alleles, which is lower than the ClinGen LCA/eoRD VCEP PM2_Supporting threshold of <0.0004 (PM2_Supporting). This variant has been reported in at least 2 probands with early-onset severe retinal dystrophy who also harbored either the NM_000180.4(GUCY2D):c.1343C>A (p.Ser448Ter) variant (suspected but not confirmed in trans, PMID:10951519) or the NM_000180.4(GUCY2D):c.3078_3083dup (p.Ile1027_Leu1028dup) variant (confirmed in trans, PMID: 34048777), each which have been previously classified as either pathogenic or likely pathogenic by the LCA/eoRD VCEP (1.5 total pts, PM3). The variant has been reported to segregate with childhood-onset severe retinal dystrophy through the proband plus 1 similarly affected relative, with the variant present in the compound heterozygous state (VCEP member-provided data, PP1). At least one proband harboring this variant exhibits a phenotype including a diagnosis of Leber congenital amaurosis (0.5 pts) with onset at age 0.3 years (1 pt), genotyping by exome sequencing with no alternative cause of retinal disease identified (4 pts), poor vision with no light perception (1 pt), roving nystagmus (1 pt), attenuated vessels (0.5 pts), and extinguished electroretinogram responses from rods (0.5 pts) and cones (1 pt), which together are highly specific for GUCY2D-related recessive retinopathy (9.5 total points, PMID: 34048777, PP4_Moderate). In summary, this variant meets the criteria to be classified as likely pathogenic for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: PM2_Supporting, PM3, PP1, and PP4_Moderate. (VCEP specifications version 1.0.0; date of approval 01/22/2025).